TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Phase II Trial of Pembrolizumab in Combination With Bevacizumab for Untreated Melanoma Brain Metastases.

Sarah A Weiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.